Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome

American Journal of Medicine

Volumn 105, Issue 3 A, 1998, Pages 35S-42S

  Glaser, Ronald ^a   Kiecolt Glaser, Janice K ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GAMMA INTERFERON; GROWTH HORMONE; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2 RECEPTOR; NORADRENALIN; PROLACTIN; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHRONIC FATIGUE SYNDROME; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INTERFERON PRODUCTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; STRESS; SYMPTOMATOLOGY; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 0032575983     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(98)00160-0     Document Type: Article

References (81)

1. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Case Definition Study Group. Ann Intern Med. 1994;121:953-959.
2. Komaroff AL, Buchwald D. Symptoms and signs in chronic fatigue syndrome. Rev Infect Dis. 1991;13:S8-S11.
3. Jones JF, Ray CG, Minnich LL, et al. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985;102:1-7.
4. Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985;102:7-16.
5. Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause? JAMA. 1987;257:2297-2302.
6. Buchwald D, Sullivan JL, Komaroff AL. Frequency of chronic active Epstein-Barr virus infection in a general medical practice. JAMA. 1987;257:2303-2307.
7. Hellinger WC, Smith TF, Van Scoy RE, et al. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA. 1988;260:971-973.
8. Krueger GR, Klueppelberg U, Hoffmann A, Ablashi DV. Clinical correlates of infection with human herpesvirus-6. In Vivo 1994;8:457-485.
9. Sairenji T, Yamanishi K, Tachibana Y, et al. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology. 1995;38:269-273.
10. Patnaik M, Komaroff AL, Conley E, et al. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis. 1995; 172:1364-1367.
11. DiLuca D, Zorzenon M, Mirandola P, et al. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol. 1995;33:1660-1661.
12. Buchwald D, Ashley RL, Pearlman T, et al. Viral serologies in patients with chronic fatigue and Chronic Fatigue Syndrome. J Med Virol. 1996;50:25-30.
13. Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego: Academic Press, 1991.
14. Joncas JH, Leyritz M. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines. Rev Can Biol. 1974; 33:135-147.
15. Magrath IT, Pizzo PA, Novikovs L, Levine AS. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. Virology. 1979;97:477-481.
16. Bauer G. Induction of Epstein-Barr virus early antigens by corticosteroids: inhibition by TPA and retinoic acid. Intl J Canc. 1983;31:291-295.
17. Glaser R, Kutz LA, MacCallum RC, Malarkey WB. Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology. 1995;62:356-361.
18. Halford WP, Gebhardt BM, Carr DJ. Mechanisms of Herpes Simplex virus type 1 reactivation. J Virol. 1996;70:5051-60.
19. Smith EM, Blalock JE. Human lymphocyte production of ACTH and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci USA. 1981;78:7530-7534.
20. Sabharwal P, Glaser R, Lafuse W, et al. Prolactin synthesis and secretion by human peripheral blood lymphocytes: an autocrine co-mitogen for lymphoproliferation. Proc Natl Acad Sci USA. 1992;89:7713-7716.
21. Varma S, Sabharwal P, Sheridan JF, Malarkey WB. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J Clin Endocrinol Metab. 1993;76:49-53.
22. Cohen S, Syme SL, eds. Social Support and Health. New York: Academic Press, 1985.
23. Kiecolt-Glaser JK, Garner W, Speicher CE, et al. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med. 1984;46:7-14.
24. Glaser R, Kiecolt-Glaser JK, Stout JC, et al. Stress-related impairments in cellular immunity. Psych Res. 1985;16:233-239.
25. Glaser R, Kiecolt-Glaser JK. "Relatively mild stress" depresses cellular immunity in healthy adults. Behav Brain Sci. 1985;8:401-402.
26. Kiecolt-Glaser JK, Glaser R, Strain E, et al. Modulation of cellular immunity in medical students. J Behav Med. 1986; 9:5-21.
27. Glaser R, Rice J, Speicher CE, et al. Stress depresses interferon production by leukocytes and natural killer cell activity in humans. Behav Neurosci. 1986;100:675-678.
28. Glaser R, Rice J, Sheridan J, et al. Stress-related immune suppression: health implications. Brain Behav Imm. 1987; 1:7-20.
29. Tomei LD, Kiecolt-Glaser JK, Kennedy S, Glaser R. Psychological stress and phorbol ester inhibition of radiation-induced apotosis in human peripheral blood leukocytes. Psych Res. 1990;33:59-71.
30. Glaser R, Kiecolt-Glaser JK, Bonneau R, et al. Stress-induced modulation of the immune response to recombinant Hepatitis B vaccine. Psychosom Med. 1992;54:22-29.
31. Glaser R, Lafuse WP, Bonneau RH, et al. Stress-associated modulation of proto-oncogene expression in human peripheral blood leukocytes. Behav Neurosci. 1993;107:525-529.
32. Glaser R, Kennedy S, Lafuse WP, et al. Psychological stress-induced modulation of IL-2 receptor gene expression and IL-2 production in peripheral blood leukocytes. Arch Gen Psych. 1990;47:707-712.
33. Kiecolt-Glaser JK, Glaser R, Dyer C, et al. Chronic stress and immunity in family caregivers for Alzheimer's Disease victims. Psychosom Med. 1987;49:523-535.
34. Kiecolt-Glaser JK, Dura JR, Speicher CE, et al. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med. 1991;53:345-362.
35. Kiecolt-Glaser JK, Glaser R. Caregivers, mental health, and immune function. In: Light E, Niederehe G, Lebowitz B, eds. Stress Effects on Family Caregivers of Alzheimer's Patients. New York: Springer Publishing, 1994:64-74.
36. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Hlth Psychol. 1994;13:291-299.
37. Esterling BA, Kiecolt-Glaser JK, Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom Med. 1996;58:264-272.
38. Glaser R, Kiecolt-Glaser JK. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann Behav Med. 1997;19:78-82.
39. Jabaaij PM, Grosheide RA, Heijtink RA, et al. Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine. J Psychosom Res. 1993;37:361-369.
40. Kiecolt-Glaser NK, Glaser R, Gravenstein S, et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA. 1996;93: 3043-3047.
41. Gravenstein S, Drinka P, Duthie EH, et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Ger Soc. 1994;42:245-251.
42. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, et al. Slowing of wound healing by psychological stress. Lancet. 1995; 346:1194-1196.
43. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325:606-612.
44. Bonneau RH, Sheridan JF, Feng N, Glaser R. Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to local and systemic Herpes simplex virus (HSV) infection. Brain Behav Imm. 1991;5:274-295.
45. Sheridan JF, Feng N, Bonneau RH, et al. Restraint stress differentially affects antiviral cellular and humoral responses in mice. J Neuroimmunology. 1991;31:245-255.
46. Bonneau RH, Sheridan JF, Feng N, Glaser R. Stress-induced suppression of Herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav Imm. 1991;5:170-192.
47. Feng N, Pagniano R, Tovar CA, et al. The effect of restraint stress on the kinetics, magnitude and isotype of the humoral immune response to influenza virus infection. Brain Behav Imm. 1991;5:370-382.
48. Bonneau FH, Sheridan JF, Feng N, Glaser R. Stress-induced modulation of the primary cellular immune response to Herpes Simplex virus infection is mediated by both adrenal-dependent and adrenal-independent mechanisms. J Neuroimmunology. 1993;42:167-176.
49. Glaser R, Kiecolt-Glaser JK. Stress-associated immune modulation and its implications for reactivation of latent herpesviruses. In: Glaser R, Jones J, eds. Human Herpesvirus Infections. New York: Marcel Dekker, 1994:245-270.
50. Luborsky L, Mintz J, Brightman VJ, Katcher AH. Herpes simplex virus and moods: a longitudinal study. J Psychosom Res. 1976;20:543-548.
51. Schmidt DD, Zyzanski S, Ellner NJ, et al. Stress as a precipitating factor in subjects with recurrent herpes labialis, J Fam Prac. 1985;20:359-366.
52. Glaser R, Strain EC, Tarr K, et al. Changes in Epstein-Barr virus antibody titers associated with aging. Proc Soc Exp Biol Med. 1985;179:352-355.
53. McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infec Dis. 1989;160:1-10.
54. Glaser R, Pearson GR, Bonneau RH, et al. Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students. Health Psychol. 1993;12:435-442.
55. Glaser R, Pearson GR, Jones JF, et al. Stress related activation of Epstein-Barr virus. Brain Behav Imm. 1991;5:219-232.
56. Mathes LE, Olsen RG, Hebebrand LC, et al. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein from feline leukemia virus. Cancer Res. 1979;39: 950-955.
57. Nair MPN, Pottathil R, Heimer EP, Schwartz SA. Immunoregulatory activities of human immunodeficiency virus (HIV proteins): effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA. 1988;85: 6498-6502.
58. Miller RL, Glaser R, Rapp F. Studies of an Epstein-Barr virus DNA polymerase. Virology. 1977;76:494-502.
59. Cheng YC, Chen JY, Hoffmann PJ, Glaser R. Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. Virology. 1980;100:334-338.
60. Cheng YC, Chen JY, Glaser R, Henle W. Frequency and levels of antibodies to Epstein-Barr virus specific DNase are elevated in patients with nasopharyngeal carcinoma, Proc Natl Acad Sci USA. 1980;77:6162-6165.
61. Tan RS, Li JS, Grill SP, et al. Demonstration of Epstein-Barr virus specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res. 1986;46:5024-5028.
62. Henle W, Henle G. Antibodies to the R component of EBV-induced early antigens in Burkitt's lymphoma may exceed in titer antibodies to EB viral capsid antigen. J Natl Cancer Inst. 1977;58:785-786.
63. Henle W, Ho HC, Henle G, et al. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases and long term survivors. J Natl Cancer Inst. 1973;51:361-369.
64. Henle G, Henle W, Klein G, et al. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Canc Inst. 1971;46:861-871.
65. Jones JF, Williams MW, Schooley RT, et al. Antibodies to Epstein-Barr virus specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intl Med. 1988;148: 1957-1960.
66. Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein-Barr Virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol. 1994;42:42-46.
67. Caligiuri MA, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with Chronic Fatigue Syndrome. J Immunol. 1987;139:3306-3313.
68. Klimas NG, Salvato RF, Morgan R, Fletcher MA. Immunological abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28:1403-1410.
69. Gold D, Bowden R, Sixbey J, et al. Chronic fatigue: a prospective clinical and virologic study. JAMA. 1990;264; 48-53.
70. Straus SE, Fritz S, Dale J, et al. Lymphocyte phenotype analysis suggests chronic immune stimulation in patients with chronic fatigue syndrome. J Clin Immunol. 1993;13: 30-40.
71. Lloyd AR, Wakefield D, Broughton CR, Dwyer JM. Immunological abnormalities in the chronic fatigue syndrome. Med J Austral. 1989;151:122-124.
72. Lloyd AR, Hickie I, Hickie C, et al. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol. 1992;87:76-79.
73. Chao CC, Gallagher M, Phair J, Peterson PK. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis. 1990;162:1412-1413.
74. Tosato G, Straus SE, Henle W, et al. Characteristic T-cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol. 1985;134:3082-3088.
75. Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med. 1989;110:321.
76. Demitrack MA. The Psychobiology of chronic fatigue: the central nervous system as a final common pathway. In: Demitrack MA, Abbey SE, eds. Chronic Fatigue Syndrome: An Integrative Approach to Evaluation and Treatment. New York: The Guilford Press, 1996;72-109.
77. Weingarten HP. Cytokines and food intake: the relevance of the immune system to the study of ingestive behavior. Neurosci Behav Revs. 1996;20:163-170.
78. Black PH. Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrob Agents Chemother. 1994;38:7-12.
79. Fricchione GL, Stefano GB. The stress response and autoimmunoregulation. Adv Neuroimmunol. 1994;4:13-27.
80. Propes MJ, Johnson RW. Role of corticosterone in the behavioral effects of central interleukin-1. Physiol Behav. 1997;61:7-13.
81. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 1995;57:1011-1026.